Haemorheological consequences of hyperglycaemic spike in healthy volunteers and insulin-dependent diabetics

被引:0
|
作者
Khodabandehlou, T [1 ]
Zhao, H
Vimeux, M
Aouane, F
Le Devehat, C
机构
[1] Ctr Hosp, Unite Rech Hemorheol Clin, F-58000 Nevers, France
[2] China Japan Friendship Hosp, Res Inst, Beijing 100029, Peoples R China
[3] Ctr Hosp, Serv Diabetol Endocrinol Nutr, F-58000 Nevers, France
关键词
hyperglycaemic spike; blood viscosity; erythrocyte aggregation; erythrocyte deformability; cell counts; TcPO2; diabetes;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study has been designed to examine the role of a hyperglycaemic spike of short duration as a factor possibly involved in haemorheological microcirculatory and (or) haemostatic dysfunctions in ten insulin-dependent diabetes mellitus patients (IDDM) and five healthy volunteers. The hyperglycaemic spike was induced by glucose infusion via GCIIS Biostator. Blood viscosity, erythrocyte aggregation, erythrocyte deformability, plasma viscosity and proteins' levels, cell counts, and transcutaneous oxygen pressure were investigated during normoglycaemic period and at the end of a 1 h hyperglycaemic spike. Hyperglycaemia induced in IDDM patients significant decreases in erythrocyte aggregation, in blood and plasma viscosities and in both fibrinogen and albumin levels. The number of platelets was significantly decreased as a result of the hyperglycaemic spike. There was no significant change induced by the hyperglycaemic spike in healthy volunteers. These findings show that a hyperglycaemic spike of 280 mg/dl (15.6 mmol/l) of short duration in IDDM patients causes numerous significant changes in both blood components and rheological behaviour. These changes were accompanied by a significant decrease in transcutaneous oxygen tension indicating an impaired tissue oxygenation during the hyperglycaemia.
引用
收藏
页码:105 / 114
页数:10
相关论文
共 50 条
  • [1] PHARMACOKINETICS OF SOMATOSTATIN ADMINISTERED BY CONTINUOUS SUBCUTANEOUS PERFUSION IN HEALTHY-VOLUNTEERS AND INSULIN-DEPENDENT DIABETICS
    ZIEGLER, O
    KOLOPP, M
    POINTEL, JP
    GARIOT, P
    TOUSSAIN, P
    CAZAUBON, C
    DROUIN, P
    DEBRY, G
    DIABETES & METABOLISM, 1988, 14 (02): : 168 - 168
  • [2] BIOAVAILABILITY OF INSULIN IN INSULIN-DEPENDENT DIABETICS
    BEUSCART, R
    FONTAINE, P
    FIALDES, P
    DHERBOMEZBOIDEIN, M
    DECAUDAVEINE, B
    LEFEBVRE, J
    FOSSATI, P
    DIABETES & METABOLISM, 1985, 11 (05): : 324 - 324
  • [3] MASTOPATHY IN INSULIN-DEPENDENT DIABETICS
    BYRD, BF
    HARTMANN, WH
    GRAHAM, LS
    HOGLE, HH
    ANNALS OF SURGERY, 1987, 205 (05) : 529 - 532
  • [4] CARE OF INSULIN-DEPENDENT DIABETICS
    FISHER, M
    PRACTITIONER, 1991, 235 (1507) : 783 - 785
  • [5] DIET OF INSULIN-DEPENDENT DIABETICS
    CALDER, J
    MEDICAL JOURNAL OF AUSTRALIA, 1973, 1 (03) : 142 - 143
  • [6] DIET OF INSULIN-DEPENDENT DIABETICS
    WOOD, B
    WOOG, W
    MEDICAL JOURNAL OF AUSTRALIA, 1972, 2 (21) : 1210 - &
  • [7] DIET OF INSULIN-DEPENDENT DIABETICS
    WHARTON, CL
    WICKING, J
    WILLS, HR
    MARTIN, FIR
    MEDICAL JOURNAL OF AUSTRALIA, 1972, 2 (13) : 707 - &
  • [8] PHENFORMIN IN INSULIN-DEPENDENT DIABETICS
    BLOOM, A
    KOLBE, RJ
    BRITISH MEDICAL JOURNAL, 1970, 1 (5697): : 660 - &
  • [9] PHENFORMIN IN INSULIN-DEPENDENT DIABETICS
    BLOOM, A
    DIABETOLOGIA, 1970, 6 (06) : 620 - &
  • [10] IMMUNOTHERAPY FOR INSULIN-DEPENDENT DIABETICS
    ROSSINI, AA
    NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (06): : 333 - 335